Bio-Rad Laboratories (BIO.B) vs Boston Scientific (BSX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bio-Rad Laboratories (BIO.B) has outperformed Boston Scientific (BSX) over the past year, gaining 28.2% versus a loss of 56.6%. Over five years, BSX leads with a -4.2% price change compared with -50.5% for BIO.B. Boston Scientific is the larger company by market cap ($60.26 billion vs $9.76 billion), about 6.2 times the size.
On valuation, Boston Scientific trades at a lower trailing P/E (16.8x vs 46.3x for Bio-Rad Laboratories). Bio-Rad Laboratories converts more of its revenue into profit, with a net margin of 29.4% versus 14.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIO.B | BSX |
|---|---|---|
| Share price | $365.08 | $41.58 |
| Market cap | $9.76B | $60.26B |
| 1-day change | 0.00% | -1.45% |
| YTD return | +17.50% | -56.39% |
| 1-year return | +28.15% | -56.64% |
| 5-year return | -50.54% | -4.19% |
| P/E ratio (TTM) | 46.27 | 16.83 |
| Forward P/E | — | 12.29 |
| EPS (TTM) | $7.89 | $2.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.58B | $20.07B |
| Revenue growth (YoY) | +0.65% | +19.87% |
| Net income (latest FY) | $759.90M | $2.89B |
| Gross margin | 51.87% | 69.01% |
| Operating margin | 1.83% | 18.00% |
| Net margin | 29.42% | 14.41% |
| 52-week high | $365.08 | $105.65 |
| 52-week low | $244.54 | $41.50 |
| Distance from 52-week high | 0.00% | -60.64% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +44.06% |
| Average volume | 6 | 19.71M |
| Shares outstanding | 5.06M | 1.45B |
| Employees | 7,450 | 59,000 |
| Sector | Healthcare | Health Care |
| Industry | Medical Devices | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Boston Scientific is about 6.2 times larger than Bio-Rad Laboratories by market value ($60.26B vs $9.76B).
- BIO.B has outperformed BSX by 84.8 percentage points over the past year.
- Bio-Rad Laboratories trades at a higher earnings multiple (46.3x vs 16.8x trailing P/E).
- Bio-Rad Laboratories is more profitable, keeping 29.4 cents of every revenue dollar as net income versus 14.4 cents for Boston Scientific.
- Boston Scientific grew revenue faster in its latest fiscal year (+19.87% vs +0.65%).
- The two companies sit in different sectors: Bio-Rad Laboratories in Healthcare and Boston Scientific in Health Care.
About Bio-Rad Laboratories
BIO.B stock →Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.
Healthcare · Medical Devices · 7,450 employees
About Boston Scientific
BSX stock →Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
Health Care · Medical/Dental Instruments · 59,000 employees
BIO.B vs BSX FAQ
Which is bigger, Bio-Rad Laboratories or Boston Scientific?
Boston Scientific (BSX) is larger, with a market capitalization of $60.26B compared with $9.76B for Bio-Rad Laboratories (BIO.B).
Which stock has performed better over the past year, BIO.B or BSX?
BIO.B returned +28.15% over the past 12 months, compared with -56.64% for BSX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BIO.B or BSX?
BSX has the lower trailing P/E at 16.8, versus 46.3 for BIO.B. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Bio-Rad Laboratories and Boston Scientific in the same industry?
No. Bio-Rad Laboratories is in the Healthcare sector, while Boston Scientific is in Health Care.